REVAZOL DSR

REVAZOL DSR provides potent acid suppression and improved gastrointestinal motility, targeting multiple mechanisms for effective management of acid-related disorders.

COMPOSITION:

• Esomeprazole 40 mg (Enteric Coated)
• Domperidone 10 mg (Immediate Release)
• Domperidone 20 mg (Sustained Release)

MODE OF ACTION:

• Esomeprazole inhibits gastric H+/K+ ATPase, reducing acid secretion.
• Domperidone stimulates gastrointestinal motility and facilitates gastric emptying.

INDICATIONS:

• Treatment of GERD and erosive esophagitis.
• Management of dyspepsia, nausea, vomiting, and bloating.

DOSAGE:

• Recommended dose: 1 tablet daily, preferably before breakfast, or as prescribed.

STORAGE: Store at room temperature not exceeding 25ᵒC, in a dry place away from direct sunlight.

DISCLAIMER: This information is intended for medical professionals and registered medical practitioners only. Use of this product should be under the supervision of a registered medical practitioner with a valid prescription.